99 related articles for article (PubMed ID: 1649298)
1. Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels.
Garcia-Villalon AL; Krause DN; Ehlert FJ; Duckles SP
J Pharmacol Exp Ther; 1991 Jul; 258(1):304-10. PubMed ID: 1649298
[TBL] [Abstract][Full Text] [Related]
2. Characterization of vascular muscarinic receptors: rabbit ear artery and bovine coronary artery.
Duckles SP; Garcia-Villalon AL
J Pharmacol Exp Ther; 1990 May; 253(2):608-13. PubMed ID: 2338650
[TBL] [Abstract][Full Text] [Related]
3. Characterization of muscarinic receptors in human, guinea pig and rat lung.
Gies JP; Bertrand C; Vanderheyden P; Waeldele F; Dumont P; Pauli G; Landry Y
J Pharmacol Exp Ther; 1989 Jul; 250(1):309-15. PubMed ID: 2746503
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
Munns M; Pennefather JN
Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic characterization of muscarinic receptors of insect brains.
Abdallah EA; Eldefrawi ME; Eldefrawi AT
Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
Zhang LB; Buxton IL
Mol Pharmacol; 1991 Dec; 40(6):952-9. PubMed ID: 1661840
[TBL] [Abstract][Full Text] [Related]
7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
8. Presence of m3 subtype muscarinic acetylcholine receptors and receptor-mediated increases in the cytoplasmic concentration of Ca2+ in Jurkat, a human leukemic helper T lymphocyte line.
Kaneda T; Kitamura Y; Nomura Y
Mol Pharmacol; 1993 Mar; 43(3):356-64. PubMed ID: 8383801
[TBL] [Abstract][Full Text] [Related]
9. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
Dauphin F; Hamel E
J Pharmacol Exp Ther; 1992 Feb; 260(2):660-7. PubMed ID: 1738116
[TBL] [Abstract][Full Text] [Related]
10. A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction.
Mahesh VK; Nunan LM; Halonen M; Yamamura HI; Palmer JD; Bloom JW
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):279-86. PubMed ID: 1540392
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding and functional characterization of muscarinic acetylcholine receptors on the TE671/RD human cell line.
Bencherif M; Lukas RJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):946-53. PubMed ID: 1646330
[TBL] [Abstract][Full Text] [Related]
12. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord.
Höglund AU; Baghdoyan HA
J Pharmacol Exp Ther; 1997 Apr; 281(1):470-7. PubMed ID: 9103533
[TBL] [Abstract][Full Text] [Related]
13. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
14. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic cholinergic receptor sites in cerebral blood vessels.
Estrada C; Krause DN
J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic dilatation and constriction of feline cerebral blood vessels are mediated by stimulation of phosphoinositide metabolism via two different muscarinic receptor subtypes.
Dauphin F; Linville DG; Hamel E
J Neurochem; 1994 Aug; 63(2):544-51. PubMed ID: 8035178
[TBL] [Abstract][Full Text] [Related]
17. Methoctramine binding sites sensitive to alkylation on muscarinic receptors from tracheal smooth muscle.
Misle AJ; Lippo de Bécemberg I; González de Alfonzo R; Alfonzo MJ
Biochem Pharmacol; 1994 Jul; 48(1):191-5. PubMed ID: 8043022
[TBL] [Abstract][Full Text] [Related]
18. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
19. Species difference in the muscarinic receptors of thoracic aorta.
Yamanaka K; Hashimoto S; Muramatsu I
J Pharmacol Exp Ther; 1986 Jun; 237(3):980-6. PubMed ID: 3754896
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1986 May; 237(2):577-82. PubMed ID: 3009794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
